Técnicas de Reproducción Humana Asistida - Euskadi.net

38. HUGHES E, COLLINS J, VANDEKERKHOVE P.
Ovulation induction with urinary follicle
stimulating hormone versus human menopausal
gonadotropin for clomiphene-resistant
polycystic ovary syndrome (Cochrane Review).
In: The Cochrane Library, Issue 1, 2000.
Oxford: Update Software.
39. HUGHES EG. The effectiveness of ovulation
induction and intrauterine insemination in the
treatment of persistent infertility: a metaanalysis.
Human Reprod 1997 Sep;12(9):1865-
72.
40. HUGHES E, COLLINS J, VANDEKERCKHOVE P.
Gonadotrophin-releasing hormone analogue as
an adjunct to gonadotropin therapy for
clomiphene-resistant polycystic ovarian
syndrome (Cochrane Review). In: The
Cochrane Library, Issue 1, 2000. Oxford:
Update Software.
41. IZARD V. Intracytoplasmic sperm injection
(ICSI) in the management of azoospermia. Prog
Urol 1999 Jun;9(3):502-8.
42. JANSSENS RM, LAMBALK CB, VERMEIDEN JP,
SCHATS R, SCHOEMAKER J.In-vitro fertilization
in a spontaneous cycle: easy, cheap and
realistic. Hum Reprod 2000 Feb;15(2):314-8.
43. KASTROP PM. Comparison between
intracytoplasmic sperm injection and in-vitro
fertilization (IVF) with high insemination
concentration after total fertilization failure in
a previous IVF attempt. Hum Reprod 1999
Jan;14(1):65-9.
44. KOTARBA D, KOTARBA J, HUGHES E. Growth
hormone for in vitro fertilization (Cochrane
Review). In: The Cochrane Library, Issue 1,
2000. Oxford: Update Software.
45. LARIZGOITIA, MD. ESTRADA, A. GARCIA-
ALTÉS. FSH-recombinante como adyuvante en
la reproducción asistida. Datos sobre eficacia
y eficiencia de la FSH recombinante en
relación con la FSH de origen urinario.
Barcelona: Agència d´Avaluació de Tecnologia
Mèdica. Servei Català de la Salut. Departament
de Sanitat i Seguretat Social. Generalitat de
Catalunya. Febrero 2000 (BRO2/2000).
46. LÓPEZ ARGUMEDO M. Inyección espermática
intracitoplasmática (ICSI). Servicio de
Evaluación de Tecnologías Sanitarias (Osteba).
2000.
47. LOPEZ ARGUMEDO M, ASUA J. Reproducción
asistida y prestaciones en el SNS. Servicio de
Evaluación de Tecnologías Sanitarias, Osteba.
2000.
48. MAMAN E, LUNENFELD E, LEVY A, VARDI H,
POTASHNIK G. Obstetric outcome of singlenton
pregnancies conceived by in vitro fertilization
and ovulation induction compared with those
conceived spontaneously. Fertil Steril 1998
Aug;70(2):240-5.
49. MARTIN-DU PAN RC. Etiology and treatment of
sterility due to azoospermia. Rev Med Suisse
Normande 1999 Nov;119(6):453-7.
50. MIKKELSEN L. Severe male infertility. Genetic
investigation and counseling prior to
intracytoplasmatic sperm injection. Ugeskr
Laeger 1999 Apr 19;161(16):2348-51.
51. MORENO C. Intracytoplasmic sperm injection
as a routine indication in low responder
patients. Hum Reprod 1998 Aug;13(8):2126-9.
52. NIKOLETTOS N. The outcome of
intracytoplasmic sperm injection in patients
with retrograde ejaculation. Hum Reprod 1999
Sept;14(9):2293-6.
53. NUGENT D, VANDEKERKHOVE P, ARNOT M,
LILFORD R. Gonadotrophins and
gonadotrophin-releasing hormone agonists for
ovulation induction in subfertility associated
with polycystic ovary syndrome (Protocol for a
Cochrane Review). In: The Cochrane Library,
Issue 1, 2000. Oxford: Update Software.
54. O´BRIEN P, VANDEKERKHOVE P. Intra-uterine
versus cervical insemination of donor sperm
for subfertility (Cochrane Review). In: The
Cochrane Library, Issue 1, 2000. Oxford:
Update Software.
55. PEINADO JA, BOLÚMAR F. Esterilidad e
infertilidad: aproximación a su incidencia y a
la demanda previsible de servicios. In: Remohi
J, Simon C, Pellicer A, Bonilla-Musoles F
editores. Reproducción Humana. 1ª ed.
Madrid: McGraw-Hill/Interamericana de
España;1996.p.235-245
81
TÉCNICAS DE REPRODUCCIÓN ASISTIDA